FDA to Review Easing Restrictions on Peptides

The U.S. Food and Drug Administration (FDA) announced this summer that it will review its restrictions on certain peptide injections. This potential loosening of regulations has received encouragement from Robert F. Kennedy Jr. and figures associated with the Trump administration. Peptides, which are short chains of amino acids, have gained popularity among wellness enthusiasts and biohackers. These individuals claim that peptide injections offer a range of benefits, including the treatment of conditions like tendonitis and the enhancement of tanning capabilities. Amanda Mull, a senior reporter for Bloomberg Businessweek, discussed these developments, highlighting the growing interest in peptides for perceived health and cosmetic advantages.